FDA asks drugmaker to stop selling its opioid painkiller

FDA asks drugmaker to stop selling its opioid painkiller


This Oct. 14, 2015 file photo shows the Food and Drug Administration campus in Silver Spring, Md. On Thursday, June 8, 2017, the FDA said it has asked Endo Pharmaceuticals to stop selling its reformulated, extended-release painkiller, Opana ER.



from Biotech News